|
Jerini AG - Company Profile Snapshot
| Company Profile: |
Jerini AG |
| Ticker: |
JI4 |
| Exchanges: |
FRA |
| 2008 Sales: |
4,428,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
GERMANY |
| Employees: |
154 |
Business Description
Jerini AG. The Group's principal activity is discovery and development of novel peptide based drugs. The Group focus on the capitalization of the potential of peptidomimetic and small molecule substrates transformed by Group's novel drug discovery method to therapeutic drugs. The Group operates through two business segments Jerini Pharma and Peptide Technologies. The Jerini Pharma segment is engaged in the discovery and development of targeted therapeutics for hereditary angioedema, liver cirrhosis, cancer and inflammatory diseases. The Peptide Technologies segment serves the life science industry and research community by producing custom and catalogue peptides using its integrated array-based technology platforms.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
